UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000034931
Receipt number R000039709
Scientific Title PhaseII study of Nivolumab monotherapy for patients with occupational cholangiocarcinoma
Date of disclosure of the study information 2019/02/01
Last modified on 2023/11/24 06:37:55

No. Disposal Last modified on Item of update
1 Insert 2018/11/19 08:07:35
2 Update 2018/11/21 14:56:13 UMIN ID1
3 Update 2019/05/22 10:55:06 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date
4 Update 2019/05/22 14:03:40 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Address
Address
Tel
Email
5 Update 2020/05/20 11:43:39 Key exclusion criteria
6 Update 2023/06/16 06:37:01 Last follow-up date
7 Update 2023/11/22 16:20:54 Recruitment status
8 Update 2023/11/24 06:37:55 Number of participants that the trial has enrolled